InvestorsHub Logo

shub

03/31/17 1:51 PM

#1404 RE: Short-Hunter #1403

Looks like overcompensation to me.
It was reasonable to think they'd have to raise cash periodically as most clinical stage bios do...Big deal.
In the past, when i see a 20% abrupt plunge in the PPS with no real change in the potential earnings power of a clinical stage bio, it's been a fine time to buy as the PPS generally recovers.

midastouch017

04/01/17 9:51 AM

#1409 RE: Short-Hunter #1403

Why buy in @ 10 cents?
Try buying @ 5, it's even
better!

:-) ;-) :-)